cimetidine has been researched along with Pituitary Neoplasms in 10 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cimetidine, which strongly stimulates prolactin release in healthy man, was unable to modify prolactin levels in prolactin-secreting pituitary adenomas." | 3.66 | Failure of drugs acting on H2-receptors to modify plasma prolactin levels in pituitary adenomas: evidence for a suprapituitary locus of action. ( Bertaccini, G; Ceda, GP; Scarpignato, C; Valenti, G, 1981) |
| "Baclofen was unable to significantly rise serum PRL levels in healthy subjects and in patients affected by prolactinoma and furthermore did not interfere with PRL rise domperidone induced." | 1.27 | [Prolactin after baclofen in healthy subjects and prolactinoma patients]. ( Carletti, P; Ferretti, GF; Marchesi, GF; Morosini, PP; Nardi, B; Sarzani, R, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Geokas, MC | 1 |
| Yalow, RS | 1 |
| Straus, EW | 1 |
| Gold, EM | 1 |
| Bacchi Modena, A | 1 |
| Vadora, E | 1 |
| Fiaschetti, D | 1 |
| Micucci, G | 1 |
| Lombardozzi, L | 1 |
| Carlson, HE | 1 |
| Chang, RJ | 1 |
| Meyer, NV | 1 |
| Lu, KH | 1 |
| Judd, HL | 1 |
| Iodice, M | 1 |
| Lombardi, G | 1 |
| Tommaselli, A | 1 |
| Rossi, R | 1 |
| Annunziato, L | 1 |
| Minozzi, M | 1 |
| Gasparoni, P | 1 |
| Rota, G | 1 |
| Fioretti, D | 1 |
| Lo Giudice, C | 1 |
| Manente, P | 1 |
| Valmachino, G | 1 |
| Conte, N | 1 |
| Scarpignato, C | 1 |
| Valenti, G | 1 |
| Ceda, GP | 1 |
| Bertaccini, G | 1 |
| Gonzalez-Villapando, C | 1 |
| Szabo, M | 1 |
| Frohman, LA | 1 |
| Luttwak, EM | 1 |
| Saltz, NJ | 1 |
| Morosini, PP | 1 |
| Carletti, P | 1 |
| Sarzani, R | 1 |
| Ferretti, GF | 1 |
| Marchesi, GF | 1 |
| Nardi, B | 1 |
| Kikuchi, Y | 1 |
| Seki, K | 1 |
| Momose, E | 1 |
| Kizawa, I | 1 |
| Oomori, K | 1 |
| Shima, K | 1 |
| Mukai, K | 1 |
| Kato, K | 1 |
10 other studies available for cimetidine and Pituitary Neoplasms
| Article | Year |
|---|---|
Peptide radioimmunoassays in clinical medicine.
Topics: Acid Phosphatase; Amylases; Animals; Cimetidine; Creatine Kinase; Dogs; Female; Gastrins; Hexosamini | 1982 |
[Role of H2 receptors in controlling prolactin release. Decreased response to cimetidine in patients with prolactin-secreting adenoma and idiopathic hyperprolactinemia].
Topics: Adenoma; Adult; Cimetidine; Female; Galactorrhea; Humans; Pituitary Neoplasms; Pregnancy; Prolactin; | 1984 |
Effect of cimetidine on serum prolactin in normal women and patients with hyperprolactinaemia.
Topics: Adolescent; Adult; Cimetidine; Female; Guanidines; Humans; Male; Middle Aged; Pituitary Neoplasms; P | 1981 |
Agreement of prolactin response to cimetidine and nomifensine in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia.
Topics: Adolescent; Adult; Cimetidine; Female; Guanidines; Humans; Isoquinolines; Male; Nomifensine; Pituita | 1982 |
[Cimetidine and primary hyperparathyroidism: failure of reduction of blood levels of parathyroid hormone in 5 cases of primary hyperparathyroidism].
Topics: Adult; Cimetidine; Female; Guanidines; Humans; Hyperparathyroidism; Male; Middle Aged; Parathyroid H | 1981 |
Failure of drugs acting on H2-receptors to modify plasma prolactin levels in pituitary adenomas: evidence for a suprapituitary locus of action.
Topics: Adenoma; Cimetidine; Female; Guanidines; Humans; Hypothalamus; Methylhistamines; Pituitary Neoplasms | 1981 |
Central nervous system-mediated stimulation of prolactin secretion by cimetidine, a histamine H2-receptor antagonist: impaired responsiveness in patients with prolactin-secreting tumors and idiopathic hyperprolactinemia.
Topics: Adenoma; Adolescent; Adult; Animals; Carbidopa; Cimetidine; Female; Guanidines; Humans; Levodopa; Ma | 1980 |
The progressive Zollinger-Ellison syndrome in multiple endocrine neoplasia.
Topics: Adult; Apudoma; Cimetidine; Follow-Up Studies; Gastrectomy; Gastrinoma; Humans; Male; Middle Aged; M | 1988 |
[Prolactin after baclofen in healthy subjects and prolactinoma patients].
Topics: Adult; Baclofen; Cimetidine; Domperidone; Dopamine; Drug Interactions; Female; Humans; Hypothalamo-H | 1985 |
Establishment and characterization of a new human cultured cell line from a prolactin-secreting pituitary adenoma.
Topics: Adenoma; Bromocriptine; Cell Division; Cell Line; Cimetidine; Estradiol; Humans; Pituitary Neoplasms | 1985 |